Comparison of Artificial Neural Network and Logistic Regression Models for Predicting In-Hospital Mortality after Primary Liver Cancer Surgery

Background Since most published articles comparing the performance of artificial neural network (ANN) models and logistic regression (LR) models for predicting hepatocellular carcinoma (HCC) outcomes used only a single dataset, the essential issue of internal validity (reproducibility) of the models has not been addressed. The study purposes to validate the use of ANN model for predicting in-hospital mortality in HCC surgery patients in Taiwan and to compare the predictive accuracy of ANN with that of LR model. Methodology/Principal Findings Patients who underwent a HCC surgery during the period from 1998 to 2009 were included in the study. This study retrospectively compared 1,000 pairs of LR and ANN models based on initial clinical data for 22,926 HCC surgery patients. For each pair of ANN and LR models, the area under the receiver operating characteristic (AUROC) curves, Hosmer-Lemeshow (H-L) statistics and accuracy rate were calculated and compared using paired T-tests. A global sensitivity analysis was also performed to assess the relative significance of input parameters in the system model and the relative importance of variables. Compared to the LR models, the ANN models had a better accuracy rate in 97.28% of cases, a better H-L statistic in 41.18% of cases, and a better AUROC curve in 84.67% of cases. Surgeon volume was the most influential (sensitive) parameter affecting in-hospital mortality followed by age and lengths of stay. Conclusions/Significance In comparison with the conventional LR model, the ANN model in the study was more accurate in predicting in-hospital mortality and had higher overall performance indices. Further studies of this model may consider the effect of a more detailed database that includes complications and clinical examination findings as well as more detailed outcome data.

[1]  Cheng-Yan Kao,et al.  Gene Expression-Based Chemical Genomics Identifies Potential Therapeutic Drugs in Hepatocellular Carcinoma , 2011, PloS one.

[2]  S. Finkelstein,et al.  Prognostic models in hepatocellular carcinoma (HCC) and statistical methodologies behind them. , 2007, Current pharmaceutical design.

[3]  Te-Wei Ho,et al.  Disease-Free Survival after Hepatic Resection in Hepatocellular Carcinoma Patients: A Prediction Approach Using Artificial Neural Network , 2012, PloS one.

[4]  E. P. Popechitelev,et al.  The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study , 1997, Hepatology.

[5]  E. Livingston,et al.  Procedure volume as a predictor of surgical outcomes. , 2010, JAMA.

[6]  Wen-Hsien Ho,et al.  Genetic-algorithm-based artificial neural network modeling for platelet transfusion requirements on acute myeloblastic leukemia patients , 2011, Expert Syst. Appl..

[7]  H. Y. Chen,et al.  Prediction of tacrolimus blood levels by using the neural network with genetic algorithm in liver transplantation patients. , 1999, Therapeutic drug monitoring.

[8]  Wen-Hsien Ho,et al.  An ANFIS-based model for predicting adequacy of vancomycin regimen using improved genetic algorithm , 2011, Expert Syst. Appl..

[9]  Maimuna Mendy,et al.  Increase in Female Liver Cancer in The Gambia, West Africa: Evidence from 19 Years of Population-Based Cancer Registration (1988–2006) , 2011, PloS one.

[10]  S. Fan,et al.  Continuous Improvement of Survival Outcomes of Resection of Hepatocellular Carcinoma: A 20-Year Experience , 2011, Annals of surgery.

[11]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[12]  W. Jarnagin Management of Small Hepatocellular Carcinoma: A Review of Transplantation, Resection, and Ablation , 2010, Annals of Surgical Oncology.

[13]  Margaret Sullivan Pepe,et al.  Assessing risk prediction models in case–control studies using semiparametric and nonparametric methods , 2010, Statistics in medicine.

[14]  F. Piscaglia,et al.  Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. , 2010, Journal of hepatology.

[15]  C. Tilquin,et al.  Risk Adjustment in Outcome Assessment: the Charlson Comorbidity Index , 1993, Methods of Information in Medicine.

[16]  S. Hyakin,et al.  Neural Networks: A Comprehensive Foundation , 1994 .

[17]  Y. Li,et al.  Association between Alcohol Consumption and Cancers in the Chinese Population—A Systematic Review and Meta-Analysis , 2011, PLoS ONE.

[18]  Maurizio Tommasini,et al.  Prediction of asymptomatic cirrhosis in chronic hepatitis C patients: accuracy of artificial neural networks compared with logistic regression models , 2009, European journal of gastroenterology & hepatology.

[19]  Hushan Yang,et al.  A Meta-Analysis of Array-CGH Studies Implicates Antiviral Immunity Pathways in the Development of Hepatocellular Carcinoma , 2011, PloS one.

[20]  Guihua Chen,et al.  A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation , 2011, PloS one.

[21]  Tung-Kuan Liu,et al.  Tuning the structure and parameters of a neural network by using hybrid Taguchi-genetic algorithm , 2006, IEEE Trans. Neural Networks.

[22]  Hong-wei Zhang,et al.  Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. , 2011, World journal of gastroenterology.

[23]  Yi Han,et al.  Overview of Artificial Neural Networks , 2009, Artificial Neural Networks.